<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Sci Monit</journal-id><journal-id journal-id-type="iso-abbrev">Med. Sci. Monit</journal-id><journal-id journal-id-type="publisher-id">Medical Science Monitor</journal-id><journal-title-group><journal-title>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research</journal-title></journal-title-group><issn pub-type="ppub">1234-1010</issn><issn pub-type="epub">1643-3750</issn><publisher><publisher-name>International Scientific Literature, Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27032876</article-id><article-id pub-id-type="pmc">4822939</article-id><article-id pub-id-type="doi">10.12659/MSM.897981</article-id><article-id pub-id-type="publisher-id">897981</article-id><article-categories><subj-group subj-group-type="heading"><subject>Animal Study</subject></subj-group></article-categories><title-group><article-title>Effects of Silk Sericin on Incision Wound Healing in a Dorsal Skin Flap Wound Healing Rat Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ersel</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="af1-medscimonit-22-1064">1</xref><xref ref-type="author-notes" rid="fn1-medscimonit-22-1064">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref><xref ref-type="author-notes" rid="fn5-medscimonit-22-1064">E</xref><xref ref-type="author-notes" rid="fn6-medscimonit-22-1064">F</xref><xref ref-type="author-notes" rid="fn7-medscimonit-22-1064">G</xref><xref ref-type="author-notes" rid="fn8-medscimonit-22-1064">*</xref><xref ref-type="corresp" rid="c1-medscimonit-22-1064"/></contrib><contrib contrib-type="author"><name><surname>Uyanikgil</surname><given-names>Yigit</given-names></name><xref ref-type="aff" rid="af2-medscimonit-22-1064">2</xref><xref ref-type="aff" rid="af3-medscimonit-22-1064">3</xref><xref ref-type="author-notes" rid="fn1-medscimonit-22-1064">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref><xref ref-type="author-notes" rid="fn5-medscimonit-22-1064">E</xref><xref ref-type="author-notes" rid="fn6-medscimonit-22-1064">F</xref><xref ref-type="author-notes" rid="fn7-medscimonit-22-1064">G</xref><xref ref-type="author-notes" rid="fn8-medscimonit-22-1064">*</xref></contrib><contrib contrib-type="author"><name><surname>Akarca</surname><given-names>Funda Karbek</given-names></name><xref ref-type="aff" rid="af1-medscimonit-22-1064">1</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Ozcete</surname><given-names>Enver</given-names></name><xref ref-type="aff" rid="af1-medscimonit-22-1064">1</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Altunci</surname><given-names>Yusuf Ali</given-names></name><xref ref-type="aff" rid="af1-medscimonit-22-1064">1</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Karabey</surname><given-names>Fatih</given-names></name><xref ref-type="aff" rid="af4-medscimonit-22-1064">4</xref><xref ref-type="author-notes" rid="fn1-medscimonit-22-1064">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Cavusoglu</surname><given-names>Turker</given-names></name><xref ref-type="aff" rid="af2-medscimonit-22-1064">2</xref><xref ref-type="aff" rid="af3-medscimonit-22-1064">3</xref><xref ref-type="author-notes" rid="fn1-medscimonit-22-1064">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Meral</surname><given-names>Ayfer</given-names></name><xref ref-type="aff" rid="af5-medscimonit-22-1064">5</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Yigitturk</surname><given-names>Gurkan</given-names></name><xref ref-type="aff" rid="af2-medscimonit-22-1064">2</xref><xref ref-type="author-notes" rid="fn2-medscimonit-22-1064">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-22-1064">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref></contrib><contrib contrib-type="author"><name><surname>Cetin</surname><given-names>Emel Oyku</given-names></name><xref ref-type="aff" rid="af6-medscimonit-22-1064">6</xref><xref ref-type="author-notes" rid="fn1-medscimonit-22-1064">A</xref><xref ref-type="author-notes" rid="fn4-medscimonit-22-1064">D</xref><xref ref-type="author-notes" rid="fn5-medscimonit-22-1064">E</xref><xref ref-type="author-notes" rid="fn6-medscimonit-22-1064">F</xref><xref ref-type="author-notes" rid="fn7-medscimonit-22-1064">G</xref></contrib></contrib-group><aff id="af1-medscimonit-22-1064"><label>1</label>Department of Emergency Medicine, Ege University, Faculty of Medicine, Bornova, Izmir, Turkey</aff><aff id="af2-medscimonit-22-1064"><label>2</label>Department of Histology and Embryology, Ege University, Faculty of Medicine, Bornova, Izmir, Turkey</aff><aff id="af3-medscimonit-22-1064"><label>3</label>Cord Blood Cell &#x02013; Tissue Research and Application Center, Ege University, Bornova, Izmir, Turkey</aff><aff id="af4-medscimonit-22-1064"><label>4</label>Department of Biotechnology, Graduate School of Natural and Applied Sciences, Ege University, Bornova, Izmir, Turkey</aff><aff id="af5-medscimonit-22-1064"><label>5</label>Department of Biochemistry, Evliya Celebi Training and Research Hospital, Faculty of Medicine, Dumlup&#x00131;nar University, Kutahya, Turkey</aff><aff id="af6-medscimonit-22-1064"><label>6</label>Department of Biopharmaceutics and Pharmacokinetics, Ege University, Faculty of Pharmacy, Bornova, Izmir, Turkey</aff><author-notes><corresp id="c1-medscimonit-22-1064">Corresponding Author: Murat Ersel, e-mail: <email>murat.ersel@gmail.com</email></corresp><fn id="fn1-medscimonit-22-1064"><label>A</label><p>Study Design</p></fn><fn id="fn2-medscimonit-22-1064"><label>B</label><p>Data Collection</p></fn><fn id="fn3-medscimonit-22-1064"><label>C</label><p>Statistical Analysis</p></fn><fn id="fn4-medscimonit-22-1064"><label>D</label><p>Data Interpretation</p></fn><fn id="fn5-medscimonit-22-1064"><label>E</label><p>Manuscript Preparation</p></fn><fn id="fn6-medscimonit-22-1064"><label>F</label><p>Literature Search</p></fn><fn id="fn7-medscimonit-22-1064"><label>G</label><p>Funds Collection</p></fn><fn id="fn8-medscimonit-22-1064"><label>*</label><p>Murat Ersel and Yigit Uyanikgil equally contributed to the this work</p></fn></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>4</month><year>2016</year></pub-date><volume>22</volume><fpage>1064</fpage><lpage>1078</lpage><history><date date-type="received"><day>09</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Med Sci Monit, 2016</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p></license></permissions><abstract><sec><title>Background</title><p>The wound healing process is complex and still poorly understood. Sericin is a silk protein synthesized by silk worms (<italic>Bombyx mori</italic>). The objective of this study was to evaluate <italic>in vivo</italic> wound healing effects of a sericin-containing gel formulation in an incision wound model in rats.</p></sec><sec><title>Material/Methods</title><p>Twenty-eight Wistar-Albino rats were divided into 4 groups (n=7). No intervention or treatment was applied to the Intact control group. For other groups, a dorsal skin flap (9&#x000d7;3 cm) was drawn and pulled up with sharp dissection. The Sham operated group received no treatment. The Placebo group received placebo gel without sericin applied to the incision area once a day from day 0 to day 9. The Sericin Group 3 received 1% sericin gel applied to the incision area once a day from day 0 to day 9. Hematoxylin and eosin stain was applied for histological analysis and Mallory-Azan staining was applied for histoimmunochemical analysis of antibodies and iNOS (inducible nitric oxide synthase), and desmin was applied to paraffin sections of skin wound specimens. Parameters of oxidative stress were measured in the wound area.</p></sec><sec><title>Results</title><p>Epidermal thickness and vascularization were increased, and hair root degeneration, edema, cellular infiltration, collagen discoloration, and necrosis were decreased in Sericin group in comparison to the Placebo group and the Sham operated group. Malonyldialdehyde (MDA) levels were decreased, but superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities were increased in the sericin group.</p></sec><sec><title>Conclusions</title><p>We found that sericin had significant positive effects on wound healing and antioxidant activity. Sericin-based formulations can improve healing of incision wounds.</p></sec></abstract><kwd-group><title>MeSH Keywords</title><kwd>Antioxidants</kwd><kwd>Sericins</kwd><kwd>Wound Healing</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>A wound is a result of a physical injury that causes damage and penetrates into the layers of the skin [<xref rid="b1-medscimonit-22-1064" ref-type="bibr">1</xref>]. Wound healing is important in terms of ensuring anatomic integrity of the skin and protecting its functional structure, and it occurs with the repair of the skin and other soft tissues [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>]. Wounds starts as a response to an injury and end with the re-establishment of the integrity and functioning of the injured area [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>].</p><p>Wound healing is a preprogrammed process consisting of 4 continuous phases [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>]: bleeding controlled by hemostasis, inflammatory response (0&#x02013;3 days), cellular proliferation (3&#x02013;12 days), and remodeling (3&#x02013;6 months) [<xref rid="b1-medscimonit-22-1064" ref-type="bibr">1</xref>,<xref rid="b4-medscimonit-22-1064" ref-type="bibr">4</xref>,<xref rid="b5-medscimonit-22-1064" ref-type="bibr">5</xref>]. The interruptions, aberrancies, and prolongations that may occur during these phases can interrupt the wound healing process and lead to non-healing chronic wounds [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>].</p><p>Hemostasis start immediately after the injury and fibrin clots are formed together with vasoconstriction. Proinflammatory cytokines and growth factors &#x02013; fibroblast growth factor (FGF), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and transforming growth factor (TGF-&#x003b2;) &#x02013; are expressed from the clot and the surrounding tissue after hemostasis. Inflammatory cells migrate to the inner side of the wound after hemostasis and start the inflammatory phase. Neutrophils, macrophages, and lymphocytes migrate to the tissue in this phase [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>].</p><p>The proliferative phase follows and overlaps with the inflammatory phase. The proliferative phase is characterized by epithelium proliferation and the migration of this epithelium to the temporary matrix in the wound (re-epithelization) [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>]. The main components of the proliferative phase are angio-neogenesis, deposition of collagen, granulation tissue formation, epithelization, and wound contraction. During angio-neogenesis, new blood vessels are formed from endothelium cells [<xref rid="b6-medscimonit-22-1064" ref-type="bibr">6</xref>]. Fibroblasts and endothelium cells are the main cells that have a role in processes of capillary growth, collagen formation, and granulation tissue formation in the wound area in reparative dermis. Fibroblasts synthesize glycosamine and proteoglycan, as well as collagen, which is the main component of the newly developing extracellular matrix [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>]. After this process, epithelial cells migrate to the other side of the wound bed and cover the wound, and the wound is covered completely by myofibroblasts, contracting the edges of the wound [<xref rid="b6-medscimonit-22-1064" ref-type="bibr">6</xref>,<xref rid="b7-medscimonit-22-1064" ref-type="bibr">7</xref>]. After the quick proliferation and extracellular matrix synthesis, the last phase, remodelling, will begin, which may last for years [<xref rid="b1-medscimonit-22-1064" ref-type="bibr">1</xref>].</p><p>In these processes, there is a coordinated influx of many neutrophils to the wound area, especially in the inflammation phase. The characteristic respiratory burst activity, which occurs due to the properties of these cells, triggers free radical formation [<xref rid="b8-medscimonit-22-1064" ref-type="bibr">8</xref>]. The non-phagocytic cells localized in the wound area produce the free radicals, which are in the non-phagocytic NAD(P)H oxidation mechanism. This situation gives rise to the increase in oxygen and nitrogen in the wound area. The appearance of these radicals results in oxidative stress that leads to lipid peroxidation and DNA breakage, as well as to the inactivation of some enzymes, including free radical scavenger enzymes [<xref rid="b1-medscimonit-22-1064" ref-type="bibr">1</xref>]. Topical application of antioxidants in wound healing has become common practice, and it has been demonstrated that components with free radical scavenging characteristics clearly improve wound healing and protect the wound from oxidative stress [<xref rid="b9-medscimonit-22-1064" ref-type="bibr">9</xref>].</p><p>Wounds caused by mechanical trauma, acute and chronic burn injuries, and pressure and foot ulcers may pose important difficulties for surgeons and emergency physicians [<xref rid="b10-medscimonit-22-1064" ref-type="bibr">10</xref>,<xref rid="b11-medscimonit-22-1064" ref-type="bibr">11</xref>]. Many studies have been conducted all over the world for the purpose of accelerating wound healing and preventing amputation or serious complications [<xref rid="b12-medscimonit-22-1064" ref-type="bibr">12</xref>]. Many chemicals and herbal substances have been tried for wound healing and ensuring maximum recovery [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>,<xref rid="b4-medscimonit-22-1064" ref-type="bibr">4</xref>,<xref rid="b6-medscimonit-22-1064" ref-type="bibr">6</xref>,<xref rid="b7-medscimonit-22-1064" ref-type="bibr">7</xref>,<xref rid="b13-medscimonit-22-1064" ref-type="bibr">13</xref>,<xref rid="b14-medscimonit-22-1064" ref-type="bibr">14</xref>]. Sericin, which is a protein synthesized by the domestic silkworm, <italic>Bombyx mori</italic>, is one of these substances. The silk protein, which is a natural polymer, is bio-synthesized from the epithelium cells in <italic>Bombyx mori</italic>. The silk proteins that are expressed to the lumens of these glands are converted into silk protein fibers [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>]. Silk is well characterized and easy to obtain.</p><p>Sericin becomes gel by itself, and forms a film when combined with some polymers by cross-linking and therefore can be used in manufacturing cosmetics and pharmaceuticals. It has been proven that sericin does not cause immunological reaction with materials that have more widespread acceptance in biological applications [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>]. In addition, it has some unique characteristics, such UV resistance, antioxidation, moisture absorbance, and biocompatibility [<xref rid="b17-medscimonit-22-1064" ref-type="bibr">17</xref>&#x02013;<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>]. It has been determined in previous empirical studies that sericin decreases the peroxyl radical activity and tyrosinase [<xref rid="b21-medscimonit-22-1064" ref-type="bibr">21</xref>], and suppresses lipid peroxidation [<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>,<xref rid="b23-medscimonit-22-1064" ref-type="bibr">23</xref>]. Sericin contributes to these antioxidant effects with the chelation to the trace elements cooper and iron, and hydroxyl groups [<xref rid="b23-medscimonit-22-1064" ref-type="bibr">23</xref>]. Sericin&#x02019;s chemical structure is shown in <xref ref-type="fig" rid="f1-medscimonit-22-1064">Figure 1</xref>.</p><p>We conducted a literature review using the keywords &#x0201c;sericin&#x0201d;, &#x0201c;wound healing&#x0201d;, and &#x0201c;antioxidants&#x0201d;, and found that there have been very few clinical and empirical studies conducted on the effects of silk protein sericin in wound healing models [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>,<xref rid="b24-medscimonit-22-1064" ref-type="bibr">24</xref>].</p><p>The present study was conducted using histochemical, immunohistochemical, and biochemical methods to determine whether sericin affects wound healing.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec><title>Extraction of sericin from cocoon</title><p>Sericin was extracted from silkworm cocoons and used as a calibration standard. To do this, the cocoons were first cut into small pieces. Then, water was added and they were autoclaved at 120&#x000b0;C for 1 h. The sericin solution was filtrated through a 1.6-&#x003bc;m filter (Whatman GF/A), then cold ethanol was added. The final ethanol concentration was 75% (v/v). The supernatant of ethanol was discarded and the settled sericin was frozen at &#x02212;80&#x000b0;C. Then, it was dried in a lyophilizer to obtain sericin powder [<xref rid="b25-medscimonit-22-1064" ref-type="bibr">25</xref>&#x02013;<xref rid="b27-medscimonit-22-1064" ref-type="bibr">27</xref>]. Sericin&#x02019;s chemical structure is shown in <xref ref-type="fig" rid="f1-medscimonit-22-1064">Figure 1</xref>.</p></sec><sec sec-type="methods"><title>Analytical methods</title><p>We used the Shimadzu Prominence Model High-Performance Liquid Chromatography (HPLC) system to perform quantitative analysis of sericin and to determine its molecular weight distribution. The HPLC system contains a Nucleogel aqua OH-40-8 gel permeation chromatography (GPC) column, and a buffer solution containing 0.05 M phosphate and 0.3 M NaCl. The analyses were all done at 30&#x000b0;C and their ultraviolet absorbances (UVA) were read at 230 nm [<xref rid="b27-medscimonit-22-1064" ref-type="bibr">27</xref>]. In sericin analysis, the flow rate of mobile phase was adjusted to 1 mL/min and it was decreased to 0.3 mL/min for the determination of molecular weight distribution. For filtration of all samples, a 0.45-&#x003bc;m filter (Millipore Millex-HV) was used, then the solution was injected into the system using a 20-&#x003bc;L syringe. For standardization of the calibration, we used sericin extracted from native silk cocoons [<xref rid="b29-medscimonit-22-1064" ref-type="bibr">29</xref>].</p></sec><sec><title>Preparation of formulations</title><sec><title>Preparation of placebo gel</title><p>Placebo gel formulation was prepared by dispersing 7.5% w/w Na-CMC in distilled water to form a homogeneous dispersion under continuous stirring until a homogeneous gel was formed.</p></sec><sec><title>Preparation of gel containing sericin</title><p>Gel formulation was prepared by dispersing 7.5% w/w Na-CMC in distilled water to form a homogeneous dispersion. We dissolved 1% sericin in distilled water, then the solution was added to the Na-CMC dispersion while stirring until the solution became a homogeneous gel [<xref rid="b30-medscimonit-22-1064" ref-type="bibr">30</xref>].</p></sec></sec><sec><title>Animal studies</title><sec><title>Animals</title><p>Twenty-eight male Wistar-Albino rats weighing 200&#x02013;220 g were used in this study. All experiments were performed after obtaining permission from the Ege University Animal Ethics Committee and according to its regulations (Permission Number: 2014-062). National guidelines on the care and use of laboratory animals were strictly followed. The animals were kept under standard conditions, with 25&#x000b1;1&#x000b0;C room temperature, 12-h light/dark cycles, in individual cages, and fed pellet diet and water ad libitum. The rats were randomly divided into 4 groups with 7 rats in each group. No intervention or treatment was applied to the Intact control group. For the Sham operated group, the Placebo group, and the Sericin group, a dorsal skin flap (9&#x000d7;3 cm) was drawn and pulled up with sharp dissection. The Sham Control group received no treatment. The Placebo group received a placebo gel applied to the incision area. The Sericin group received a gel containing 1% sericin applied to the incision area. The rats were treated immediately in the Placebo group with placebo gel and the Sericin group was treated with sericin gel. All formulations were applied to animals once a day from day 0 until day 9.</p></sec></sec><sec><title>Incision wound model</title><p>Anesthesia were used for all the animals prior to and during the experimental interventions. Dorsal fur of the rats was shaved before infliction of the experimental wounds. The surgical interventions were carried out under sterile conditions using ketamine hydrochloride (75 mg/kg) and xylazine (8 mg/kg) anesthesia intraperitoneally. On the dorsal side of rats, a caudally-based 9&#x000d7;3 cm (27 cm<sup>2</sup>) dorsal skin flap was drawn and pulled up by sharp dissection as described by Khouri et al. [<xref rid="b31-medscimonit-22-1064" ref-type="bibr">31</xref>]. The entire flap was undermined below the level of the <italic>panniculus carnosus.</italic> Incisions were closed with 4/0 silk surgical sutures placed 1 cm apart to the parted skin of the animals. The wounds were left undressed. Total operation time was 15 min for every rat [<xref rid="b32-medscimonit-22-1064" ref-type="bibr">32</xref>].</p></sec><sec><title>Wound healing</title><p>Under ether anesthesia, gel formulations were applied over the flaps once a day and repeated every day for 9 days. The gel formulations were evenly applied in sufficient amounts covering all the surface of the wound area.</p><p>On the 9<sup>th</sup> day after the initial operation, flap viability was evaluated. Rats were reanesthetized for evaluation of the viability of the flap tissues on the 10<sup>th</sup> postoperative day. Six slices were randomly selected from each individual animal in a group and 5 separate measurements were made in each slice to determine epidermal thickness and necrotic area. The dorsal skin flaps were photographed with a digital camera (Canon A 610, Japan). A mechanism using a tripod was used to standardize all images, and images were taken from equal distances. By calculation of the necrotic tissue percentage, necrotic skin surface was defined by the necrotic skin borders, and total flap areas were delineated by surgical borders of the flaps.</p><p>The animals were sacrificed by high-dose ketamine hydrochloride administered intramuscularly. When the animals were sacrificed, a skin biopsy was taken from the beginning of the 3 cm distal of the flap base and 1 cm width. For the histopathological analysis, we investigated tissue degeneration of skin biopsy samples fixed in 10% buffered formalin under a light microscope.</p></sec><sec sec-type="methods"><title>Histopathological analysis</title><p>After fixation of the skin biopsy samples in 10% buffered formalin for 24 h, routine paraffin wax embedding procedures were used and samples were blocked. About 5-&#x003bc;m sections were cut using a Leica RM 2145 model microtome (Germany) then stained with both hematoxylin and eosin and Mallory azan staining. Sections were investigated at a magnification of 40&#x000d7; and examined the thickness of their epithelium. After taking digital photos (Olympus BX51 Light Microscope, Olympus C5050 Digital Camera, Japan) at a magnification of 20&#x000d7;, necrotic skin and total flap area border were determined with the aid of a software program (Image Pro Express Version 4.5.1.3., Media Cybernetics Inc., 2002, USA).</p></sec><sec sec-type="methods"><title>Immunohistochemical analysis</title><p>To analyze the immunohistochemical expressions, anti-iNOS and anti-desmin antibodies were used. Paraffin sections were immersed in xylene overnight and incubated in methanol containing 3% H<sub>2</sub>O<sub>2</sub> to reduce endogenous peroxidase activity. Sections were heated in sodium citrate solution in a microwave oven at 90 W for 5 min and at 360 W for 15 min. Subsequently, sections were incubated in primary antibodies (anti-desmin, Bioss, bs-1026R, USA; 1/100 and anti-iNOS, Santa Cruz, Sc-651, USA; 1/100) for 24 h at 4&#x000ba;C. Antibody detection was performed with the Histostain-Plus Bulk kit (Bioss, Inc) against rabbit IgG, and 3,3&#x02032; diaminobenzidine (DAB) was used to visualize the final product. Immunoreaction was assessed by light microscopy (Olympus BX-51 light microscope, Olympus C-5050 digital camera) at 40&#x000d7; magnification.</p></sec><sec><title>Histological scoring</title><p>The tissue edema and collagen discoloration grading were scored as: normal=0; mild increase=1; mild to moderate increase=2; moderate increase=3; moderate to marked increase=4; and marked increase=5. For the purpose of expressing the cellular infiltration grading, the scoring obtained by counting the total inflammatory cells (lymphocytes, neutrophils, macrophages, eosinophils, plasma cells, and mast cells) for each section per high-power field (HPF) (400&#x000d7;). According to this scoring, a score of 0 = &#x0003c;3 inflammatory cells, 1 = 3&#x02013;10 inflammatory cells, 2 = 11&#x02013;20 inflammatory cells, 3 = 21&#x02013;30 inflammatory cells, 4 = 31&#x02013;40 inflammatory cells, and 5 = &#x0003e;41 inflammatory cells [<xref rid="b33-medscimonit-22-1064" ref-type="bibr">33</xref>].</p></sec><sec sec-type="methods"><title>Biochemical analysis</title><p>After the routine skin tissue homogenization and centrifuge processes, the BioVision brand Glutathione Peroxidase Activity Colorimetric Assay Kit was used to determine the GSH. The reading was performed using a BMG LABTECH 96 Microplate Reader at 340 nm.</p><p>To determine the MDA in the tissue, the BioVision brand Lipid Peroxidation (MDA) Colorimetric/Fluorometric Assay Kit was used, and the measurements were used with the Colorimetric method. The reading was performed using a BMG LABTECH 96 Microplate Reader at 532 nm. A BioVision brand Catalase Activity Colorimetric/Fluorometric Assay Kit was used with the Colorimetric method to determine the catalase in the tissue. The reading was performed with a BMG LABTECH 96 Microplate Reader at 570 nm. We used a Beckman Coulter AU640 brand auto-analyzer applique and a Randox Ransod brand commercial kit to determine the SOD activity in the tissue.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Data are expressed as percentages, numbers, median, and mean &#x000b1;SD. Statistical comparison of the groups was performed using SPSS Version 22.0 (Chicago, Illinois, USA). The Kruskal-Wallis test was used to analyze the significant difference between groups in number of total hair roots, number of degenerated hair roots, number of vessels, epidermal thickness and percentage of the necrotic area around the flap, biochemical analysis of GPx, SOD, catalase, and MDA levels in the flap biopsy. When significance was determined, the Mann-Whitney U test was used for post hoc analysis. A <italic>P</italic> value below 0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="results"><title>Results</title><sec sec-type="methods"><title>Analytical methods</title><p>HPLC was used for quantitative analysis of sericin and determining its molecular weight distribution. The HPLC chromatogram is shown in <xref ref-type="fig" rid="f2-medscimonit-22-1064">Figure 2</xref>. The sericin was eluted as a broad peak between 6.5 and 11.0 min.</p></sec><sec sec-type="results"><title>Histopathological results</title><sec><title>Intact Control Group</title><p>Normal skin histological structure was observed. Five different layer structures were determined, stretching from the basal to the stratum corneum in epidermis. Normal histologic structure was observed in the glandular structures, which are called <italic>glandula sebacea,</italic> expressing their holocrine degenerative secretions to hair follicles. The hair follicles started from the dermis and extended through the epidermis and opened to the surface. The glandular structures were located in the bottom area of the hair follicles. The irregular tight collagen tissue, which hosted collagen bundles stretching every direction in the dermis, was determined to be normal. The structure, which is rich in fat tissue and connects the skin defined as hypodermis to the tissues in deeper areas, was normal (<xref ref-type="fig" rid="f3-medscimonit-22-1064">Figures 3A</xref>, <xref ref-type="fig" rid="f4-medscimonit-22-1064">4A</xref>, <xref ref-type="fig" rid="f5-medscimonit-22-1064">5A</xref>, <xref ref-type="fig" rid="f6-medscimonit-22-1064">6A</xref>).</p></sec><sec><title>Sham Operated Group</title><p>Histologic structure of the wound lips was determined. There was decreased epidermis thickness. Degeneration was determined in the hair roots. The degenerative findings in the sebaceous glands in the hair roots and the areas hosting the hair roots were observed to be smaller than those in the Intact control group. We also observed that the amount and distribution of collagen in collagen bundles stretching in every direction in the dermis were significantly greater than the intact control group, and that this was in the direction of scar formation (<xref ref-type="fig" rid="f3-medscimonit-22-1064">Figures 3B</xref>, <xref ref-type="fig" rid="f4-medscimonit-22-1064">4B</xref>, <xref ref-type="fig" rid="f5-medscimonit-22-1064">5B</xref>, <xref ref-type="fig" rid="f6-medscimonit-22-1064">6B</xref>).</p></sec><sec><title>Placebo Group</title><p>We determined that the Placebo Group was similar to the Intact control group in terms of histopathology, and the epidermis was thinner than in the Intact control group. The scar formation, collagen discoloration, decrease in the hair roots, and the histopathological image in the <italic>glandula sebacea</italic> structures were similar to those in the Sham operated group (<xref ref-type="fig" rid="f3-medscimonit-22-1064">Figures 3C</xref>, <xref ref-type="fig" rid="f4-medscimonit-22-1064">4C</xref>, <xref ref-type="fig" rid="f5-medscimonit-22-1064">5C</xref>, <xref ref-type="fig" rid="f6-medscimonit-22-1064">6C</xref>).</p></sec><sec><title>Sericin Group</title><p>We determined that the epidermis thickness was closer to that of the Intact control group, and was thicker than in the Sham operated group and the Placebo group. The degenerative findings in the hair roots were less than in the Sham operated group and the Placebo group, and was closer to that of the Intact control group, as was the case with epidermis thickness. There were similarities in collagen distribution, scar formation, and collagen discoloration (<xref ref-type="fig" rid="f3-medscimonit-22-1064">Figures 3D</xref>, <xref ref-type="fig" rid="f4-medscimonit-22-1064">4D</xref>, <xref ref-type="fig" rid="f5-medscimonit-22-1064">5D</xref>, <xref ref-type="fig" rid="f6-medscimonit-22-1064">6D</xref>).</p><p>After the histopathological evaluation of the samples, the parameters on wound healing were evaluated. The total number of the hair follicles, the number of the degenerated hair follicles, and the number of the unaffected vessels are given in <xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>; the epidermis thickness and necrotic tissue percentage are given in <xref ref-type="table" rid="t2-medscimonit-22-1064">Table 2</xref>; and the edema, cellular infiltration, and collagen discoloration are given in <xref ref-type="table" rid="t3-medscimonit-22-1064">Tables 3</xref><xref ref-type="table" rid="t4-medscimonit-22-1064"/>&#x02013;<xref ref-type="table" rid="t5-medscimonit-22-1064">5</xref>, respectively.</p></sec></sec><sec><title>The number of the total hair roots</title><p>When the samples that were obtained after the tenth day were compared in terms of the number of the total hair roots, a significant difference was found among the 4 groups (KW&#x003c7;<sup>2</sup>, p&#x0003c;0.0001) (<xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>). The groups were compared as pairs using the Mann-Whitney U test as post hoc analysis. After these comparisons, we determined that there was a statistically significant difference between the Intact control group and the Sericin group (p=0.002) and between the Sericin group and the Sham operated group (p=0.003) and the Placebo group (p=0.008). At the end of the tenth day, the Sericin group had more hair roots than the Sham operated group and the Placebo group.</p></sec><sec><title>Number of degenerated hair roots</title><p>When the samples taken were examined in terms of the number of degenerative hair roots, we observed that there was significant difference among the 4 groups (KW&#x003c7;<sup>2</sup>, p=0.001) (<xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>). There was no hair root degeneration in the Intact control group, but there was a statistically significant difference between the Sericin group and the Sham operated group (p=0.002) and the Placebo group (p=0.002) after post hoc analyses (Mann-Whitney U test). On the tenth day, there were less degenerated hair roots in the Sericin group than in the Sham operated group and the Placebo group (<xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>).</p></sec><sec><title>Number of vessels</title><p>When the sections were examined according to the number of the vessels, we found a significant difference among all the groups in terms of the total number of the vessels (KW&#x003c7;<sup>2</sup>, p&#x0003c;0.0001) (<xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>). The groups were compared as pairs by using the Mann-Whitney U test as post hoc analysis, showing a statistically significant difference between the Intact control group and the Sericin group (p=0.002), and between the Sericin group and the Sham operated group (p=0.002) and the Placebo group (p=0.002). There were more intact vessels in the Sericin group than the Sham operated group and the Placebo group (<xref ref-type="table" rid="t1-medscimonit-22-1064">Table 1</xref>).</p></sec><sec><title>Epidermal thickness</title><p>When the samples taken from the study groups were compared in terms of the epidermal thickness values, there was a statistically significant difference among all the groups (KW&#x003c7;<sup>2</sup> p&#x0003c;0.0001) (<xref ref-type="table" rid="t2-medscimonit-22-1064">Table 2</xref>). The groups were compared in pairs by using the Mann-Whitney U test as post hoc analysis. It was determined after the comparisons that there was a statistically significant difference between the Intact control group and the Sericin group (p=0.004), and the between the Sericin group and the Sham operated group (p=0.002) and the Placebo group (p=0.002). At the end of the tenth day, the Sericin group had more epidermal thickness than the Sham operated group and the Placebo group.</p></sec><sec><title>Percentage of the necrotic tissue</title><p>Statistically significant differences were determined between the Sham operated group, the Placebo group, and the Sericin group in terms of necrotic tissue percentage in the section areas (KW&#x003c7;<sup>2</sup>, p&#x0003c;0.0001) (<xref ref-type="table" rid="t2-medscimonit-22-1064">Table 2</xref>). No necrosis was observed in the Intact control group because there were no incisions. The groups were compared as pairs by using the Mann-Whitney U test as post hoc analysis, showing that the necrotic tissue percentage in the Sericin group was lower than in the Placebo group (p=0.002) and the Sham operated group (p=0.002). At the end of the tenth day, the sericin application limited the formation of necrotic tissue in the sections.</p></sec><sec><title>Cellular infiltration</title><p>There were significant differences among the study groups in terms of cellular infiltration scores. The infiltration scores in the Intact control group were 0&#x02013;1, the infiltration scores in the Sericin group were 1&#x02013;2, the scores in the Sham operated group were 3&#x02013;5, and the scores in the Placebo group were 3&#x02013;4. We found less cellular infiltration in the Sericin group than in the Placebo group and the Sham operated group (<xref ref-type="table" rid="t3-medscimonit-22-1064">Table 3</xref>).</p></sec><sec><title>Degree of edema</title><p>The edema was graded in all groups. The edema scores according to group are given in <xref ref-type="table" rid="t4-medscimonit-22-1064">Table 4</xref>. When the study groups were compared in terms of edema grades, the scores were 0&#x02013;1 in the Intact control group; 0&#x02013;3 in the Sericin group (but mostly 1&#x02013;2), and the edema scores in the Sham operated group and the Placebo group were distributed in a balanced manner at higher scores (4&#x02013;5). The edema scores were distributed at lower levels in the Sericin group than in the Sham operated group and the Placebo group (<xref ref-type="table" rid="t4-medscimonit-22-1064">Table 4</xref>).</p></sec><sec><title>Collagen discoloration</title><p>Collagen discoloration observed in the tissues in all study groups was scored and the results are given in <xref ref-type="table" rid="t5-medscimonit-22-1064">Table 5</xref>. Scores were 0&#x02013;1 in the Intact control group and 1&#x02013;2 in the Sericin group, but in the Sham operated group and the Placebo group the scores were mostly 3&#x02013;4. The collagen discoloration scores in the Sericin group were lower than in the Sham operated group and the Placebo group.</p></sec><sec sec-type="results"><title>Immunohistochemical results</title><sec><title>Anti-iNOS staining</title><p>Anti-iNOS staining in the Control group showed immunoreaction in sebaceous glands, hair follicles, and epidermis. While there was intense immune-positivity in the Intact control group after the incision wound, there was less immune-positivity in the Sham operated group and the Placebo group. The Sericin group showed an immunohistochemical reaction similar to that in the Control group (<xref ref-type="fig" rid="f5-medscimonit-22-1064">Figure 5</xref>).</p></sec><sec><title>Anti-desmin staining</title><p>It was observed in the control group that the muscle that is immune-positive in anti-Desmin staining <italic>musculus erector pillia</italic> was located in the hair roots in longitudinal form. It was determined that these muscles were placed in a short and flat manner in the Placebo group, and had degenerative findings in parts. In the Sericin group, on the other hand, it was observed that this structure was similar to that of the Control group, and that it was long and the muscle structure was protected (<xref ref-type="fig" rid="f6-medscimonit-22-1064">Figure 6</xref>).</p></sec></sec><sec sec-type="results"><title>Biochemical results</title><p>At the end of the biochemical analyses, the oxidative stress markers and the antioxidant enzyme levels were determined. According to these analyses, the MDA (malonyldialdehyde), which appears after lipid peroxidation and which is an oxidative stress marker, was determined as being significantly lower in the Sericin group than in the Placebo and Sham operated group (<xref ref-type="table" rid="t6-medscimonit-22-1064">Table 6</xref>; p&#x0003c;0,001). GPx (Glutathione Peroxidase), SOD (Superoxide Dismutase), and catalase, which are important antioxidant defense enzymes, were significantly higher in the Sericin group than in the Sham operated group and the Placebo group (p&#x0003c;0.001).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Wound healing is a natural response to tissue damage. The healing process includes cellular activity that forms a complex cascade. After this activity, the resurfacing, reconstruction, and the restoration of the wound tensile power is ensured [<xref rid="b34-medscimonit-22-1064" ref-type="bibr">34</xref>]. Limitation of keloid formation is important as well as the development of wound tensile strength [<xref rid="b35-medscimonit-22-1064" ref-type="bibr">35</xref>]. Healing of incision wounds without leaving scars is the goal of medical and surgical practices. The basic aim in wound healing is the restoration of the connective tissue and fast wound closure. The desired outcomes in this process are minimal pain, minimal discomfort, and minimal scar formation [<xref rid="b7-medscimonit-22-1064" ref-type="bibr">7</xref>]. Various medications and medical dressing materials have been developed and used to accelerate wound healing and optimize the healing process [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>,<xref rid="b4-medscimonit-22-1064" ref-type="bibr">4</xref>,<xref rid="b6-medscimonit-22-1064" ref-type="bibr">6</xref>,<xref rid="b7-medscimonit-22-1064" ref-type="bibr">7</xref>,<xref rid="b10-medscimonit-22-1064" ref-type="bibr">10</xref>,<xref rid="b13-medscimonit-22-1064" ref-type="bibr">13</xref>,<xref rid="b36-medscimonit-22-1064" ref-type="bibr">36</xref>].</p><p><italic>Bombyx mori</italic> synthesizes silk that consists of 2 types of proteins: fibroin and sericin. Fibroin has a fibril structure and accounts for 70% of the structure of pure silk. Sericin, on the other hand, is a sticky water-soluble protein and surrounds and connects the fibroin fibers [<xref rid="b37-medscimonit-22-1064" ref-type="bibr">37</xref>]. Fibroin is used in production of raw textiles and in some bio-material applications. On the other hand, sericin is regarded as waste material in the textile industry [<xref rid="b29-medscimonit-22-1064" ref-type="bibr">29</xref>]. It has been demonstrated in recent years that sericin has proliferative effects on some cell membranes, and also has various other biological activities. In previous <italic>in vivo</italic> and <italic>in vitro</italic> studies, sericin has been used in gauze bandages or medical dressings and was applied as ointment [<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>&#x02013;<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>,<xref rid="b38-medscimonit-22-1064" ref-type="bibr">38</xref>&#x02013;<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>].</p><p>Sericin increases the attachment and proliferation of skin fibroblasts, osteoblasts, and keratinocytes [<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>,<xref rid="b41-medscimonit-22-1064" ref-type="bibr">41</xref>&#x02013;<xref rid="b43-medscimonit-22-1064" ref-type="bibr">43</xref>], and clearly increases collagen production and epithelization [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>,<xref rid="b44-medscimonit-22-1064" ref-type="bibr">44</xref>,<xref rid="b45-medscimonit-22-1064" ref-type="bibr">45</xref>]. In addition, sericin can be used an antioxidant, antibacterial, coagulant, and moisturizer [<xref rid="b18-medscimonit-22-1064" ref-type="bibr">18</xref>,<xref rid="b44-medscimonit-22-1064" ref-type="bibr">44</xref>,<xref rid="b46-medscimonit-22-1064" ref-type="bibr">46</xref>&#x02013;<xref rid="b48-medscimonit-22-1064" ref-type="bibr">48</xref>].</p><p>A recent study determined that silver sulfadiazine preparations containing sericin increased the collagen production in burn patients and decreased the pain [<xref rid="b38-medscimonit-22-1064" ref-type="bibr">38</xref>]. Aramwith et al. investigated the use of 8% sericin formulation in empirical incisional wound models with a different empirical method and reported decreased inflammation in the wound area and reduced wound size [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>]. There were no ulcerations, and, as the amount of collagen was increased, wound healing was accelerated [<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>].</p><p>The present study, which used a wound healing model formed with a dorsal graft, showed that sericin was superior to the placebo in all criteria. Hair root degeneration was prevented in rats treated with sericin, and epidermal thickness and number of vessels, which is an important finding of wound healing, was significant higher than in the Placebo group and Sham operated group. Epidermal thickness provides clues about scar formation. If epidermal thickness is less, the chance of scar formation is greater [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>]. We found that epidermal thickness was clearly greater in rats treated with sericin. The optimization of collagen synthesis as a result of fibroblast activity [<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>] increased by sericin might have accelerated the epidermal healing process.</p><p>The necrotic tissue area percentage around the incision areas in Sericin group rats was significantly lower compared with the Placebo group and the Sham operated group, suggesting that sericin limits necrosis, perhaps by limiting lipid peroxidation in the tissues. MDA, a marker of oxidative stress, was significantly lower in the Sericin group. The enzymes GPx, SOD, and catalase help the body deal with oxidative stress and were detected at much higher levels in the Sericin group. Depending on the decrease in oxidative stress in wound healing studies, there is a direct relationship between wound healing and prevention of scar tissue formation [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>,<xref rid="b13-medscimonit-22-1064" ref-type="bibr">13</xref>,<xref rid="b16-medscimonit-22-1064" ref-type="bibr">16</xref>,<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>&#x02013;<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>,<xref rid="b49-medscimonit-22-1064" ref-type="bibr">49</xref>,<xref rid="b50-medscimonit-22-1064" ref-type="bibr">50</xref>].</p><p>After incision injuries, additional tissue damage and edema are caused by disruption of vascular integrity, initial neutrophil infiltration to tissue in the inflammation phase, and cells in this area producing protease and reactive oxygen species (ROS) to eliminate infection and cellular debris in the wound area [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>]. When the 4 study groups were evaluated in terms of edema and cellular infiltration, the lowest edema and cellular infiltration scores were found in the Sericin group. Another secondary activity of macrophages is the clearing of apoptotic cells (mainly neutrophils) and ensuring the resolution of inflammation [<xref rid="b3-medscimonit-22-1064" ref-type="bibr">3</xref>]. Previous studies reported that sericin increases the activity and number of macrophages [<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>]. The observed decrease in edema might have been contributed to by the limitation of cellular infiltration by sericin due to its antioxidant effects and ROS scavenging activity [<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>,<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>]; the limitation of effects of mediators like plasma-activated C3a and C5a; transforming growth factors &#x003b2; and &#x003b1;, and PDGF [<xref rid="b51-medscimonit-22-1064" ref-type="bibr">51</xref>], which cause infiltration; and the sequestration by the increased number of macrophages.</p><p>One of the important conditions for wound healing is sufficient circulation to correct tissue ischemia [<xref rid="b2-medscimonit-22-1064" ref-type="bibr">2</xref>]. Angio-neogenesis increases oxygen levels and promotes collagen synthesis and cell proliferation [<xref rid="b52-medscimonit-22-1064" ref-type="bibr">52</xref>]. When we consider the results of the study, the positive effects of sericin are clearly observed in terms of vascularization. Vascularization was at a much higher level in sections obtained from rats treated with sericin compared with the other groups. The histopathological examination in this study explored the effects of sericin on wound healing by applying a dorsal skin flap model directly to the incision area, showing that the sections of the Sericin group were similar to the Intact control group in terms of collagen distribution, scar formation, and collagen discoloration. These results reveal the positive effects of sericin on wound healing.</p><p>The collagen discoloration, which is an important parameter of wound healing, was limited in the Sericin group, and did not reach the deeper areas of the dermis from the epidermal layer. Collagen discoloration was clearly increased in the Sham operated group and the Placebo groups, which did not receive sericin. In addition, Mallory-Azan staining (<xref ref-type="fig" rid="f4-medscimonit-22-1064">Figure 4</xref>) showed that the collagen was in a more effective form and in a structure that supported connective tissue formation. Motta et al. revealed that collagen led to properly modulated collagen lysis and prepared the way for healthier fibroblast proliferation [<xref rid="b53-medscimonit-22-1064" ref-type="bibr">53</xref>]. The optimization of collagen use in the Sericin group might be explained by increased collagen synthesis [<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>]. As a last item, the decrease observed in the Sericin group in terms of collagen discoloration might be caused by increased scavenger activity [<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>]. It was used more effectively in connective tissue formation (<xref ref-type="fig" rid="f4-medscimonit-22-1064">Figure 4</xref>) because of the collagen-optimized fibroblast activity [<xref rid="b53-medscimonit-22-1064" ref-type="bibr">53</xref>], and an image supporting the connective tissue formation emerged.</p><p>Nitric oxide (NO) has a role in wound healing similar to that of the conductor of an orchestra. It has been shown in <italic>in vitro</italic> [<xref rid="b54-medscimonit-22-1064" ref-type="bibr">54</xref>] and <italic>in vivo</italic> studies that it influences macrophages, fibroblasts, and keratinocytes, and ensures coordination among cells during wound healing [<xref rid="b55-medscimonit-22-1064" ref-type="bibr">55</xref>]. NO is an important cellular signaling protein which has a role in many vital processes [<xref rid="b56-medscimonit-22-1064" ref-type="bibr">56</xref>]. NO is synthesized in 3 different forms by nitric oxide synthetase from the amino acid L-arginine [<xref rid="b57-medscimonit-22-1064" ref-type="bibr">57</xref>]. Many cells can synthesize NO with cellular endothelial or inducible nitric oxide synthase (iNOS) enzymes in wound healing [<xref rid="b58-medscimonit-22-1064" ref-type="bibr">58</xref>,<xref rid="b59-medscimonit-22-1064" ref-type="bibr">59</xref>]. Zhao et al. showed that iNOS may play crucial roles in all wound healing processes [<xref rid="b60-medscimonit-22-1064" ref-type="bibr">60</xref>].</p><p>It has been revealed in many studies that the decrease in NO synthesis decreases collagen deposition and increases wound fragility [<xref rid="b61-medscimonit-22-1064" ref-type="bibr">61</xref>&#x02013;<xref rid="b63-medscimonit-22-1064" ref-type="bibr">63</xref>]. The effects of NO on keratinocytes were tested in photo-damaged skin, in different models formed in skin incisions, and in burn injuries, showing that decreased NOS activity led to decrease in epithelium proliferation in the wound types in all models [<xref rid="b55-medscimonit-22-1064" ref-type="bibr">55</xref>].</p><p>Sericin might have directed the function of collagen in wound healing with its antioxidant activity and with the increase in NO levels [<xref rid="b57-medscimonit-22-1064" ref-type="bibr">57</xref>,<xref rid="b60-medscimonit-22-1064" ref-type="bibr">60</xref>]. Using anti-iNOS staining, we found that the i-NOS activity in the tissue occurs in epidermis and <italic>glandula sebaceas</italic>.</p><p>While the anti-iNOS expression in the Intact control group and the Placebo groups was limited, in the Sericin group we found that the i-NOS activity in tissues was increased. The high NO levels detected in tissues show the positive effect of decreasing oxidative stress in wound healing [<xref rid="b60-medscimonit-22-1064" ref-type="bibr">60</xref>].</p><p>Desmin, vicilin, and vimentin were expressed in <italic>arrector pili</italic> and smooth muscles. Desmin is a key sub-unit in the intermediate filaments of the cardiac, skeleton, and smooth muscles, and is a muscle-specific protein [<xref rid="b64-medscimonit-22-1064" ref-type="bibr">64</xref>]. The <italic>arrector pili</italic> muscles are small muscles that are connected to hair follicles in mammals and are responsible for piloerection [<xref rid="b65-medscimonit-22-1064" ref-type="bibr">65</xref>]. These muscles and sebaceous glands (follicular unit structures) are important markers in healthy skin structure [<xref rid="b66-medscimonit-22-1064" ref-type="bibr">66</xref>]. For this reason, evaluation of these muscles in skin biopsies is a strong information source. Desmin <italic>arrector pili</italic> is a marker used in showing the muscle damage [<xref rid="b67-medscimonit-22-1064" ref-type="bibr">67</xref>]. Clarkson and Tremblay used immune expressions of desmin for measurement of muscle damage [<xref rid="b68-medscimonit-22-1064" ref-type="bibr">68</xref>].</p><p>We found more intact hair roots in and around the incision area in the Sericin group together with anti-desmin staining. The Sericin group had more hair roots than the other incision groups. In addition, we observed in the histological examination that there were more hair roots in the Sericin group. We found that the condition of the <italic>m. erector pili</italic> located near the hair roots was due to the protection against oxidative stress after sericin application. Therefore, the condition of <italic>m. erector pili</italic> in the Sericin group was closer to that of the Control group than the other incision groups.</p><p>Free radicals and antioxidants negatively influence wound healing by triggering oxidative stress. This ROS elimination may be a critical point in wound healing [<xref rid="b69-medscimonit-22-1064" ref-type="bibr">69</xref>]. There are some studies in the literature showing the antioxidant effects of sericin [<xref rid="b21-medscimonit-22-1064" ref-type="bibr">21</xref>,<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>,<xref rid="b49-medscimonit-22-1064" ref-type="bibr">49</xref>]. Sericin exhibits high ROS-scavenging activity [<xref rid="b20-medscimonit-22-1064" ref-type="bibr">20</xref>,<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>].</p><p>MDA, which appears due to lipid peroxidation, is a very harmful substance that influences the ion change in the cell membranes and disrupts the permeability, gains a mutagenic character by having a reaction with DNA bases, and blocks cellular metabolism, leading to cytotoxicity [<xref rid="b50-medscimonit-22-1064" ref-type="bibr">50</xref>,<xref rid="b67-medscimonit-22-1064" ref-type="bibr">67</xref>]. In the present study, the MDA levels were found to be significantly lower higher in the Placebo group and the Sham operated group. Our results agree with the results reported by Dash et al. [<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>].</p><p>Different defense mechanisms act in preventing lipid peroxidation. These mechanisms are the structures that decrease the activity of free oxygen radicals or limit the reactions of the structures like hydrogen peroxide or hydro-peroxides, and are called antioxidants [<xref rid="b70-medscimonit-22-1064" ref-type="bibr">70</xref>]. An important part of the antioxidant defense consists of special enzymes clearing O<sub>2</sub><sup>&#x02212;</sup> and H<sub>2</sub>O<sub>2</sub>. These are the superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glucose-6-phosphate dehydrogenase enzymes [<xref rid="b71-medscimonit-22-1064" ref-type="bibr">71</xref>]. The enzymes whose levels were determined in the present study &#x02013; glutathione peroxidase (GPx), catalase, and superoxide dismutase (SOD) &#x02013; are the antioxidant enzymes. While glutathione shows its antioxidant activity by joining to the free radicals in the medium and by preventing the oxidative damage of the cell, it also shows its activity by holding the sulfhydryl groups in the proteins at a reduced status, and by preventing inactivation that may appear in the proteins and enzymes [<xref rid="b72-medscimonit-22-1064" ref-type="bibr">72</xref>]. In our study, the Sericin group had higher GPx levels. SOD is the enzyme that provides the first defense in oxygen toxicity against the production of free oxygen radicals and catalyzes the conversion of O<sub>2</sub> to H<sub>2</sub>O<sub>2</sub> [<xref rid="b73-medscimonit-22-1064" ref-type="bibr">73</xref>]. This enzyme level was significantly higher in the Sericin group. As the last item, the catalase levels were also clearly higher in the Sericin group.</p><p>All of these biochemical tests show that sericin limits the effects of oxidative stress at the cellular level. Although epidermal thickness, controlled collagen use, and vascularization are important factors in wound healing, sericin can prevent oxidative stress and affect wound healing in a positive way [<xref rid="b19-medscimonit-22-1064" ref-type="bibr">19</xref>,<xref rid="b22-medscimonit-22-1064" ref-type="bibr">22</xref>,<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>]. However, the main positive effect of sericin in wound healing may come from its potent anti-oxidative characteristics [<xref rid="b40-medscimonit-22-1064" ref-type="bibr">40</xref>].</p><sec><title>Limitations</title><p>Our study focused on short-term wound healing effects of sericin, which overlaps with the proliferation phase. However, to evaluate the long-term effects of sericin on wound healing, other parameters need to be investigated, such as scar formation, decrease in infection rates, keloid formation ratio, skin integrity, and tensile strength of the wound. Further studies are needed to investigate parameters involved in the remodeling phase of wound healing.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In the Sericin group we found increased epidermal thickness and vascularization and decreased necrosis, hair root degeneration, cellular infiltration, and collagen discoloration. Histopathological analysis showed that the Sericin group had values similar to those obtained in the Control group in terms of collagen distribution, discoloration, and scar formation in wound healing.</p><p>In addition to these results, the clearly lower levels of oxidative stress markers in the Sericin group emphasize the potent antioxidant characteristics of sericin and provide strong proof that sericin may be useful as an agent to optimize wound healing via its anti-oxidative effect. Our study of the effects of sericin on wound healing used histopathological and biochemical methods, and showed that sericin has positive effects in the wound healing process. These positive effects of sericin in wound healing must be evaluated in human clinical studies.</p></sec></body><back><fn-group><fn id="fn9-medscimonit-22-1064"><p><bold>Conflicting interests</bold></p><p>The authors declare no conflicting interests.</p></fn><fn id="fn10-medscimonit-22-1064"><p><bold>Source of support:</bold> Departmental sources</p></fn></fn-group><ref-list><title>References</title><ref id="b1-medscimonit-22-1064"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>B</given-names></name><name><surname>Vijayakumar</surname><given-names>M</given-names></name><name><surname>Govindarajan</surname><given-names>R</given-names></name><name><surname>Pushpangadan</surname><given-names>P</given-names></name></person-group><article-title>Ethnopharmacological approaches to wound healing &#x02013; exploring medicinal plants of India</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>114</volume><fpage>103</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">17884316</pub-id></element-citation></ref><ref id="b2-medscimonit-22-1064"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetin</surname><given-names>EO</given-names></name><name><surname>Yesil-Celiktas</surname><given-names>O</given-names></name><name><surname>Cavusoglu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Incision wound healing activity of pine bark extract containing topical formulations: A study with histopathological and biochemical analyses in albino rats</article-title><source>Pharmazie</source><year>2013</year><volume>68</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">23444785</pub-id></element-citation></ref><ref id="b3-medscimonit-22-1064"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>DiPietro</surname><given-names>LA</given-names></name></person-group><article-title>Factors affecting wound healing</article-title><source>J Dent Res</source><year>2010</year><volume>89</volume><fpage>219</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">20139336</pub-id></element-citation></ref><ref id="b4-medscimonit-22-1064"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>VK</given-names></name><name><surname>Paliwal</surname><given-names>SK</given-names></name></person-group><article-title>Wound-healing activity of ethanolic and aqueous extracts of Ficus benghalensis</article-title><source>J Adv Pharm Technol Res</source><year>2011</year><volume>2</volume><fpage>110</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">22171302</pub-id></element-citation></ref><ref id="b5-medscimonit-22-1064"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxson</surname><given-names>S</given-names></name><name><surname>Lopez</surname><given-names>EA</given-names></name><name><surname>Yoo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Concise review: Role of mesenchymal stem cells in wound repair</article-title><source>Stem Cells Transl Med</source><year>2012</year><volume>1</volume><fpage>142</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">23197761</pub-id></element-citation></ref><ref id="b6-medscimonit-22-1064"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayak</surname><given-names>BS</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Pinto Pereira</surname><given-names>LM</given-names></name></person-group><article-title>Evaluation of wound-healing potential of Catharanthus roseus leaf extract in rats</article-title><source>Fitoterapia</source><year>2007</year><volume>78</volume><fpage>540</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17683880</pub-id></element-citation></ref><ref id="b7-medscimonit-22-1064"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duque</surname><given-names>AP</given-names></name><name><surname>Pinto</surname><given-names>NC</given-names></name><name><surname>Mendes</surname><given-names>RF</given-names></name><etal/></person-group><article-title><italic>In vivo</italic> wound healing activity of gels containing Cecropia pachystachya leaves</article-title><source>J Pharm Pharmacol</source><year>2016</year><volume>68</volume><issue>1</issue><fpage>128</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">26727296</pub-id></element-citation></ref><ref id="b8-medscimonit-22-1064"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babior</surname><given-names>BM</given-names></name><name><surname>Curnutte</surname><given-names>JT</given-names></name><name><surname>McMurrich</surname><given-names>BJ</given-names></name></person-group><article-title>The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst</article-title><source>J Clin Invest</source><year>1976</year><volume>58</volume><fpage>989</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">9426</pub-id></element-citation></ref><ref id="b9-medscimonit-22-1064"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiem</surname><given-names>B</given-names></name><name><surname>Grosslinka</surname><given-names>O</given-names></name></person-group><article-title>Antimicrobial activity of Rubus chamaemorus leaves</article-title><source>Fitoterapia</source><year>2003</year><volume>75</volume><fpage>93</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">14693229</pub-id></element-citation></ref><ref id="b10-medscimonit-22-1064"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akturk</surname><given-names>O</given-names></name><name><surname>Tezcaner</surname><given-names>A</given-names></name><name><surname>Bilgili</surname><given-names>H</given-names></name><etal/></person-group><article-title>Evaluation of sericin/collagen membranes as prospective wound dressing biomaterial</article-title><source>J Biosci Bioeng</source><year>2011</year><volume>112</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">21697006</pub-id></element-citation></ref><ref id="b11-medscimonit-22-1064"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicks</surname><given-names>BA</given-names></name><name><surname>Ayello</surname><given-names>EA</given-names></name><name><surname>Woo</surname><given-names>K</given-names></name><etal/></person-group><article-title>Acute wound management: Revisiting the approach to assessment, irrigation, and closure considerations</article-title><source>Int J Emerg Med</source><year>2010</year><volume>3</volume><fpage>399</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">21373312</pub-id></element-citation></ref><ref id="b12-medscimonit-22-1064"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>A</given-names></name><name><surname>Rasik</surname><given-names>AM</given-names></name><name><surname>Jain</surname><given-names>GK</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> and <italic>in vivo</italic> wound healing activity of asiaticoside isolated from <italic>Centella asiatica</italic></article-title><source>J Ethnopharmacol</source><year>1999</year><volume>65</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">10350364</pub-id></element-citation></ref><ref id="b13-medscimonit-22-1064"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dilsiz</surname><given-names>OY</given-names></name><name><surname>Akhundzada</surname><given-names>I</given-names></name><name><surname>Bilkay</surname><given-names>U</given-names></name><etal/></person-group><article-title>Effects of metoclopramide and ranitidine on survival of flat template mcfarlane skin flaps in a rat wound healing model</article-title><source>Drug Res</source><year>2013</year><volume>63</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="b14-medscimonit-22-1064"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayar</surname><given-names>H</given-names></name><name><surname>Gergerlioglu</surname><given-names>N</given-names></name><name><surname>Seringec</surname><given-names>N</given-names></name><etal/></person-group><article-title>Comparison of efficacy of topical phenytoin with hypericin in second-degree burn wound healing: An experimental study in rats</article-title><source>Med Sci Monit Basic Res</source><year>2014</year><volume>20</volume><fpage>36</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">24694757</pub-id></element-citation></ref><ref id="b15-medscimonit-22-1064"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>GH</given-names></name><name><surname>Diaz</surname><given-names>F</given-names></name><name><surname>Jacuba</surname><given-names>C</given-names></name><etal/></person-group><article-title>Silk-based biomaterials</article-title><source>Biomaterials</source><year>2003</year><volume>24</volume><fpage>401</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">12423595</pub-id></element-citation></ref><ref id="b16-medscimonit-22-1064"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aramwit</surname><given-names>P</given-names></name><name><surname>Sangcakul</surname><given-names>A</given-names></name></person-group><article-title>The effects of sericin cream on wound healing in rats</article-title><source>Biosci Biotechnol Biochem</source><year>2007</year><volume>71</volume><fpage>2473</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">17928707</pub-id></element-citation></ref><ref id="b17-medscimonit-22-1064"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YQ</given-names></name></person-group><article-title>Applications of natural silk protein sericin in biomaterials</article-title><source>Biotechnol Adv</source><year>2002</year><volume>20</volume><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">14538058</pub-id></element-citation></ref><ref id="b18-medscimonit-22-1064"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>A</given-names></name><etal/></person-group><article-title>Silk protein, sericin, inhibits lipid peroxidation and tyrosinase activity</article-title><source>Biosci Biotechnol Biochem</source><year>1998</year><volume>62</volume><fpage>145</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9501526</pub-id></element-citation></ref><ref id="b19-medscimonit-22-1064"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname><given-names>R</given-names></name><name><surname>Acharya</surname><given-names>C</given-names></name><name><surname>Bindu</surname><given-names>PC</given-names></name><name><surname>Kundu</surname><given-names>SC</given-names></name></person-group><article-title>Antioxidant potential of silk protein sericin against hydrogen peroxide-induced oxidative stress in skin fibroblasts</article-title><source>BMB Rep</source><year>2008</year><volume>41</volume><fpage>236</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18377728</pub-id></element-citation></ref><ref id="b20-medscimonit-22-1064"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manosroi</surname><given-names>A</given-names></name><name><surname>Boonpisuttinant</surname><given-names>K</given-names></name><name><surname>Winitchai</surname><given-names>S</given-names></name><etal/></person-group><article-title>Free radical scavenging and tyrosinase inhibition activity of oils and sericin extracted from Thai native silkworms (<italic>Bombyx mori</italic>)</article-title><source>Pharm Biol</source><year>2010</year><volume>48</volume><fpage>855</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">20673171</pub-id></element-citation></ref><ref id="b21-medscimonit-22-1064"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takechi</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>R</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><etal/></person-group><article-title>Antioxidant activities of two sericin proteins extracted from cocoon of silkworm (<italic>Bombyx mori</italic>) measured by DPPH, chemiluminescence, ORAC and ESR methods</article-title><source>Biomed Rep</source><year>2014</year><volume>2</volume><fpage>364</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">24748975</pub-id></element-citation></ref><ref id="b22-medscimonit-22-1064"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chlapanidas</surname><given-names>T</given-names></name><name><surname>Farag&#x000f2;</surname><given-names>S</given-names></name><name><surname>Lucconi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sericins exhibit ROS-scavenging, anti-tyrosinase, anti-elastase, and <italic>in vitro</italic> immunomodulatory activities</article-title><source>Int J Biol Macromol</source><year>2013</year><volume>58</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">23541552</pub-id></element-citation></ref><ref id="b23-medscimonit-22-1064"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>RJ</given-names></name><name><surname>Modasiya</surname><given-names>MK</given-names></name></person-group><article-title>Sericin: Pharmaceutical applications</article-title><source>International Journal of Research in Pharmaceutical and Biomedical Sciences</source><year>2011</year><volume>2</volume><fpage>913</fpage><lpage>17</lpage></element-citation></ref><ref id="b24-medscimonit-22-1064"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>A novel poly(&#x003b3;-glutamic acid)/silk-sericin hydrogel for wound dressing: Synthesis, characterization and biological evaluation</article-title><source>Mater Sci Eng C Mater Biol Appl</source><year>2015</year><volume>48</volume><fpage>533</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">25579954</pub-id></element-citation></ref><ref id="b25-medscimonit-22-1064"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurioka</surname><given-names>A</given-names></name><name><surname>Kurioka</surname><given-names>F</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name></person-group><article-title>Characterization of sericin powder prepared from citric acid degraded sericin polypeptides of silkworm, <italic>Bombyx mori</italic></article-title><source>Biosci Biotechnol Biochem</source><year>2004</year><volume>68</volume><fpage>774</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15118302</pub-id></element-citation></ref><ref id="b26-medscimonit-22-1064"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>SY</given-names></name></person-group><article-title>Preparation and characterization of sericin powder extracted from silk industry wastewater</article-title><source>Food Chemistry</source><year>2007</year><volume>103</volume><fpage>1255</fpage><lpage>62</lpage></element-citation></ref><ref id="b27-medscimonit-22-1064"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaithanomsat</surname><given-names>P</given-names></name><name><surname>Kitpreechavanich</surname><given-names>V</given-names></name></person-group><article-title>Sericin separation from silk degumming wastewater</article-title><source>Sep Purif Technol</source><year>2008</year><volume>59</volume><fpage>129</fpage><lpage>33</lpage></element-citation></ref><ref id="b28-medscimonit-22-1064"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogino</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interfacial behavior of fatty-acylated sericin prepared by lipase-catalyzed solid phase synthesis</article-title><source>Biosci Biotechnol Biochem</source><year>2006</year><volume>70</volume><fpage>66</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">16428822</pub-id></element-citation></ref><ref id="b29-medscimonit-22-1064"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capar</surname><given-names>G</given-names></name><name><surname>Aygun</surname><given-names>SS</given-names></name><name><surname>Gecit</surname><given-names>MR</given-names></name></person-group><article-title>Separation of sericin from fatty acids towards its recovery from silk degumming wastewaters</article-title><source>Journal of Membrane Science</source><year>2009</year><volume>342</volume><fpage>179</fpage><lpage>89</lpage></element-citation></ref><ref id="b30-medscimonit-22-1064"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Kanazawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Sustained-release of protein from biodegradable sericin film, gel and sponge</article-title><source>Int J Pharm</source><year>2011</year><volume>407</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">21238562</pub-id></element-citation></ref><ref id="b31-medscimonit-22-1064"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khouri</surname><given-names>RK</given-names></name><name><surname>Angel</surname><given-names>MF</given-names></name><name><surname>Edstrom</surname><given-names>LE</given-names></name></person-group><article-title>Standardizing the dorsal rat flap</article-title><source>Surg Forum</source><year>1986</year><volume>37</volume><fpage>590</fpage></element-citation></ref><ref id="b32-medscimonit-22-1064"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>HP</given-names></name><name><surname>Hunt</surname><given-names>TK</given-names></name></person-group><article-title>Effects of cortisone and vitamin A on wound healing</article-title><source>Ann Surg</source><year>1968</year><volume>167</volume><fpage>324</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">5638517</pub-id></element-citation></ref><ref id="b33-medscimonit-22-1064"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaim</surname><given-names>SF</given-names></name><name><surname>Gillette</surname><given-names>RL</given-names></name><name><surname>Sartin</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Effects of a hydrolyzed collagen dressing on the healing of open wounds in dogs</article-title><source>Am J Vet Res</source><year>2000</year><volume>61</volume><fpage>1574</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">11131601</pub-id></element-citation></ref><ref id="b34-medscimonit-22-1064"><label>34</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>PE</given-names></name></person-group><source>Skin wound healing</source><comment>Available from: URL: <ext-link ext-link-type="uri" xlink:href="http://emedicine.medscape.com/article/884594-overview#showall">http://emedicine.medscape.com/article/884594-overview#showall</ext-link>. Updated: Jan 20, 2016</comment></element-citation></ref><ref id="b35-medscimonit-22-1064"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>G</given-names></name><name><surname>De Francesco</surname><given-names>F</given-names></name><name><surname>Mele</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Clinical and histologic effects from CO<sub>2</sub> laser treatment of keloids</article-title><source>Lasers Med Sci</source><year>2013</year><volume>28</volume><fpage>957</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22907426</pub-id></element-citation></ref><ref id="b36-medscimonit-22-1064"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinno</surname><given-names>H</given-names></name><name><surname>Malholtra</surname><given-names>M</given-names></name><name><surname>Lutfy</surname><given-names>J</given-names></name><etal/></person-group><article-title>Topical application of complement C3 in collagen formulation increases early wound healing</article-title><source>J Dermatolog Treat</source><year>2013</year><volume>24</volume><fpage>141</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">22007700</pub-id></element-citation></ref><ref id="b37-medscimonit-22-1064"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Magoshi</surname><given-names>J</given-names></name><name><surname>Magoshi</surname><given-names>Y</given-names></name><name><surname>Becker</surname><given-names>MA</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name></person-group><article-title>Biospinning (silk fiber formation, multiple spinning mechanisms)</article-title><person-group person-group-type="editor"><name><surname>Salamone</surname><given-names>JC</given-names></name></person-group><source>Polymeric Materials Encyclopedia</source><publisher-loc>New York NY, USA</publisher-loc><publisher-name>CRC Press</publisher-name><year>1996</year><fpage>667</fpage></element-citation></ref><ref id="b38-medscimonit-22-1064"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aramwit</surname><given-names>P</given-names></name><name><surname>Palapinyo</surname><given-names>S</given-names></name><name><surname>Srichana</surname><given-names>T</given-names></name><etal/></person-group><article-title>Silk sericin ameliorates wound healing and its clinical efficacy in burn wounds</article-title><source>Arch Dermatol Res</source><year>2013</year><volume>305</volume><fpage>585</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">23748948</pub-id></element-citation></ref><ref id="b39-medscimonit-22-1064"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanokpanont</surname><given-names>S</given-names></name><name><surname>Damrongsakkul</surname><given-names>S</given-names></name><name><surname>Ratanavaraporna</surname><given-names>J</given-names></name><name><surname>Aramwit</surname><given-names>P</given-names></name></person-group><article-title>An innovative bi-layered wound dressing made of silk and gelatin for accelerated wound healing</article-title><source>Int J Pharm</source><year>2012</year><volume>436</volume><fpage>141</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">22771972</pub-id></element-citation></ref><ref id="b40-medscimonit-22-1064"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siritienthong</surname><given-names>T</given-names></name><name><surname>Ratanavaraporn</surname><given-names>J</given-names></name><name><surname>Aramwit</surname><given-names>P</given-names></name></person-group><article-title>Development of ethyl alcohol-precipitated silk sericin/polyvinyl alcohol scaffolds for accelerated healing of full-thickness wounds</article-title><source>Int J Pharm</source><year>2012</year><volume>439</volume><fpage>175</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">23022662</pub-id></element-citation></ref><ref id="b41-medscimonit-22-1064"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sericin, a protein derived from silkworms, accelerates the proliferation of several mammalian cell lines including a hybridoma</article-title><source>Cytotechnology</source><year>2002</year><volume>40</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19003099</pub-id></element-citation></ref><ref id="b42-medscimonit-22-1064"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubouchi</surname><given-names>K</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><name><surname>Takasu</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>Sericin enhances attachment of cultured human skin fibroblasts</article-title><source>Biosci Biotechnol Biochem</source><year>2005</year><volume>69</volume><fpage>403</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15725668</pub-id></element-citation></ref><ref id="b43-medscimonit-22-1064"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion</article-title><source>Biomaterials</source><year>2008</year><volume>29</volume><fpage>4751</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18829101</pub-id></element-citation></ref><ref id="b44-medscimonit-22-1064"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aramwit</surname><given-names>P</given-names></name><name><surname>Kanokpanont</surname><given-names>S</given-names></name><name><surname>Nakpheng</surname><given-names>T</given-names></name><name><surname>Srichana</surname><given-names>T</given-names></name></person-group><article-title>The effect of sericin from various extraction methods on cell viability and collagen production</article-title><source>Int J Mol Sci</source><year>2010</year><volume>11</volume><fpage>2200</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">20559510</pub-id></element-citation></ref><ref id="b45-medscimonit-22-1064"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aramwit</surname><given-names>P</given-names></name><name><surname>Siritientong</surname><given-names>T</given-names></name><name><surname>Kanokpanont</surname><given-names>S</given-names></name><name><surname>Srichana</surname><given-names>T</given-names></name></person-group><article-title>Formulation and characterization of silk sericin-PVA scaffold crosslinked with genipin</article-title><source>Int J Biol Macromol</source><year>2010</year><volume>47</volume><fpage>668</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">20804781</pub-id></element-citation></ref><ref id="b46-medscimonit-22-1064"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamada</surname><given-names>Y</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Niwa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Sulfation of silk sericin and anticoagulant activity of sulfated sericin</article-title><source>J Biomater Sci Polym Ed</source><year>2004</year><volume>15</volume><fpage>971</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15461184</pub-id></element-citation></ref><ref id="b47-medscimonit-22-1064"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhaorigetu</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Supplemental silk protein, sericin, suppresses colon tumorigenesis in 1,2-dimethylhydrazine-treated mice by reducing oxidative stress and cell proliferation</article-title><source>Biosci Biotechnol Biochem</source><year>2001</year><volume>65</volume><fpage>2181</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11758907</pub-id></element-citation></ref><ref id="b48-medscimonit-22-1064"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhaorigetu</surname><given-names>S</given-names></name><name><surname>Yanaka</surname><given-names>N</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse</article-title><source>J Photochem Photobiol B</source><year>2003</year><volume>71</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">14705634</pub-id></element-citation></ref><ref id="b49-medscimonit-22-1064"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Sikkaa</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name></person-group><article-title>Sericin supplementation improves semen freezability of buffalo bulls by minimizing oxidative stress during cryopreservation</article-title><source>Anim Reprod Sci</source><year>2015</year><volume>152</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">25497424</pub-id></element-citation></ref><ref id="b50-medscimonit-22-1064"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ennamany</surname><given-names>R</given-names></name><name><surname>Marzetto</surname><given-names>S</given-names></name><name><surname>Saboureau</surname><given-names>D</given-names></name><name><surname>Creppy</surname><given-names>EE</given-names></name></person-group><article-title>Lipid peroxidation induced by Boletus satanas: implication in m5dC variation in Vero cells related to inhibition of cell growth</article-title><source>Cell Biol Toxicol</source><year>1995</year><volume>11</volume><fpage>347</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">8788210</pub-id></element-citation></ref><ref id="b51-medscimonit-22-1064"><label>51</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Habif</surname><given-names>TP</given-names></name></person-group><article-title>Dermatologic surgical procedures</article-title><person-group person-group-type="editor"><name><surname>Habif</surname><given-names>TP</given-names></name></person-group><source>Clinic Dermatology: A Color Guide to Diagnosis and Therapy</source><edition>3rd ed</edition><publisher-loc>Philedelphia, PA</publisher-loc><publisher-name>Mosby</publisher-name><year>1996</year><fpage>809</fpage><lpage>10</lpage></element-citation></ref><ref id="b52-medscimonit-22-1064"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muthukumar</surname><given-names>T</given-names></name><name><surname>Anbarasu</surname><given-names>K</given-names></name><name><surname>Prakash</surname><given-names>D</given-names></name><name><surname>Sastry</surname><given-names>TP</given-names></name></person-group><article-title>Effect of growth factors and pro-inflammatory cytokines by the collagen biocomposite dressing material containing <italic>Macrotyloma uniflorum</italic> plant extract-<italic>in vivo</italic> wound healing</article-title><source>Colloids Surf B Biointerfaces</source><year>2014</year><volume>121</volume><fpage>178</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">24981560</pub-id></element-citation></ref><ref id="b53-medscimonit-22-1064"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motta</surname><given-names>G</given-names></name><name><surname>Ratto</surname><given-names>GB</given-names></name><name><surname>De Barbieri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Can heterologous collagen enhance the granulation tissue growth? An experimental study</article-title><source>Ital J Surg Sci</source><year>1983</year><volume>13</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">6355005</pub-id></element-citation></ref><ref id="b54-medscimonit-22-1064"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boissel</surname><given-names>JP</given-names></name><name><surname>Ohly</surname><given-names>D</given-names></name><name><surname>Bros</surname><given-names>M</given-names></name><name><surname>G&#x000f6;dtel-Armbrust</surname><given-names>U</given-names></name><name><surname>F&#x000f6;rstermann</surname><given-names>U</given-names></name><name><surname>Frank</surname><given-names>S</given-names></name></person-group><article-title>The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes</article-title><source>J Invest Dermatol</source><year>2004</year><volume>123</volume><fpage>132</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">15191553</pub-id></element-citation></ref><ref id="b55-medscimonit-22-1064"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>Heiko Kampfer</surname><given-names>H</given-names></name><name><surname>Wetzler</surname><given-names>C</given-names></name><name><surname>Pfeilschifter</surname><given-names>J</given-names></name></person-group><article-title>Nitric oxide drives skin repair: Novel functions of an established mediator</article-title><source>Kidney Int</source><year>2002</year><volume>61</volume><fpage>882</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">11849442</pub-id></element-citation></ref><ref id="b56-medscimonit-22-1064"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>YC</given-names></name><name><surname>Janczuk</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>PG</given-names></name></person-group><article-title>Current trends in the development of nitric oxide donors</article-title><source>Curr Pharm Des</source><year>1999</year><volume>5</volume><fpage>417</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10390607</pub-id></element-citation></ref><ref id="b57-medscimonit-22-1064"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>MB</given-names></name><name><surname>Barbul</surname><given-names>A</given-names></name></person-group><article-title>Role of nitric oxide in wound repair</article-title><source>Am J Surg</source><year>2002</year><volume>183</volume><fpage>406</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11975928</pub-id></element-citation></ref><ref id="b58-medscimonit-22-1064"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>LJ</given-names></name><name><surname>Leong</surname><given-names>M</given-names></name><name><surname>Sonstein</surname><given-names>J</given-names></name></person-group><article-title>Optimization and validation of an ischemic wound model</article-title><source>Wound Rep Reg</source><year>2005</year><volume>13</volume><fpage>576</fpage><lpage>82</lpage></element-citation></ref><ref id="b59-medscimonit-22-1064"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deuel</surname><given-names>TF</given-names></name><name><surname>Senior</surname><given-names>RM</given-names></name><name><surname>Huang</surname><given-names>JS</given-names></name><name><surname>Griffin</surname><given-names>GL</given-names></name></person-group><article-title>Chemotaxis of monocytes and neutrophils to platelet-derived growth factor</article-title><source>J Clin Invest</source><year>1982</year><volume>69</volume><fpage>1046</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">7076844</pub-id></element-citation></ref><ref id="b60-medscimonit-22-1064"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Guan</surname><given-names>DW</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name></person-group><article-title>Immunohistochemical study on expression of iNOS and eNOS during skin incised wound healing in mice</article-title><source>Fa Yi Xue Za Zhi</source><year>2005</year><volume>21</volume><fpage>161</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16259358</pub-id></element-citation></ref><ref id="b61-medscimonit-22-1064"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>MR</given-names></name><name><surname>Tantry</surname><given-names>U</given-names></name><name><surname>Thornton</surname><given-names>FJ</given-names></name><name><surname>Barbul</surname><given-names>A</given-names></name></person-group><article-title>Inhibition of nitric oxide synthesis in wounds: Pharmacology and effect on accumulation of collagen in wounds in mice</article-title><source>Eur J Surg</source><comment>199</comment><volume>165</volume><fpage>262</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">10231662</pub-id></element-citation></ref><ref id="b62-medscimonit-22-1064"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>MR</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><name><surname>Thornton</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Nitric oxide, an autocrine regulator of wound fibroblast synthetic function</article-title><source>J Immunol</source><year>1997</year><volume>158</volume><fpage>2375</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">9036987</pub-id></element-citation></ref><ref id="b63-medscimonit-22-1064"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>MR</given-names></name><name><surname>Tantry</surname><given-names>U</given-names></name><name><surname>Gross</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Nitric oxide regulates wound healing</article-title><source>J Surg Res</source><year>1996</year><volume>63</volume><fpage>237</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8661204</pub-id></element-citation></ref><ref id="b64-medscimonit-22-1064"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulin</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>Desmin: A major intermediate filament protein essential for the structural integrity and function of muscle</article-title><source>Exp Cell Res</source><year>2004</year><volume>301</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15501438</pub-id></element-citation></ref><ref id="b65-medscimonit-22-1064"><label>65</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cormack</surname><given-names>DH</given-names></name></person-group><source>Essential histology</source><edition>2nd ed</edition><publisher-loc>Pennslyvania (PA)</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><year>2001</year><fpage>292</fpage></element-citation></ref><ref id="b66-medscimonit-22-1064"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narisawa</surname><given-names>Y</given-names></name><name><surname>Kohda</surname><given-names>H</given-names></name></person-group><article-title>Arrector pili muscles surround human facial vellus hair follicles</article-title><source>Br J Dermatol</source><year>1993</year><volume>129</volume><fpage>138</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">7654571</pub-id></element-citation></ref><ref id="b67-medscimonit-22-1064"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marbini</surname><given-names>A</given-names></name><name><surname>Gemignani</surname><given-names>F</given-names></name><name><surname>Bellanova</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases</article-title><source>J Neurol Sci</source><year>1996</year><volume>143</volume><fpage>156</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">8981315</pub-id></element-citation></ref><ref id="b68-medscimonit-22-1064"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarkson</surname><given-names>PM</given-names></name><name><surname>Tremblay</surname><given-names>I</given-names></name></person-group><article-title>Exercise-induced muscle damage, repair, and adaptation in humans</article-title><source>J Appl Physiol</source><year>1988</year><volume>65</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3403453</pub-id></element-citation></ref><ref id="b69-medscimonit-22-1064"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikhal&#x02019;chik</surname><given-names>EV</given-names></name><name><surname>Anurov</surname><given-names>MV</given-names></name><name><surname>Titkova</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Activity of antioxidant enzymes in the skin during surgical wounds</article-title><source>Bull Exp Biol Med</source><year>2006</year><volume>142</volume><fpage>667</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17603665</pub-id></element-citation></ref><ref id="b70-medscimonit-22-1064"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comporti</surname><given-names>M</given-names></name></person-group><article-title>Lipid peroxidation. Biopathological significance</article-title><source>Mol Aspects Med</source><year>1993</year><volume>14</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">8264334</pub-id></element-citation></ref><ref id="b71-medscimonit-22-1064"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>AJ</given-names></name><name><surname>Barnett</surname><given-names>AH</given-names></name><name><surname>Lunec</surname><given-names>JL</given-names></name></person-group><article-title>Free radicals and antioxidant systems in health and diseases</article-title><source>British J Hosp Med</source><year>1990</year><volume>43</volume><fpage>334</fpage><lpage>44</lpage></element-citation></ref><ref id="b72-medscimonit-22-1064"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Akkus</surname><given-names>I</given-names></name></person-group><article-title>Free radicals and their physiopathologic impacts</article-title><source>Serbest Radikaller ve Fizyopatolojik Etkileri</source><edition>1st ed</edition><publisher-loc>Konya, Turkey</publisher-loc><publisher-name>Mimoza Publishing</publisher-name><year>1995</year></element-citation></ref><ref id="b73-medscimonit-22-1064"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>F</given-names></name><name><surname>Giulivi</surname><given-names>C</given-names></name></person-group><article-title>Superoxide dismutases and their impact upon human health</article-title><source>Mol Aspects Med</source><year>2005</year><volume>26</volume><fpage>340</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">16099495</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-medscimonit-22-1064" position="float"><label>Figure 1</label><caption><p>Chemical structure of sericin.</p></caption><graphic xlink:href="medscimonit-22-1064-g001"/></fig><fig id="f2-medscimonit-22-1064" position="float"><label>Figure 2</label><caption><p>HPLC spectrum of sericin (concentration=2.5 mg/mL).</p></caption><graphic xlink:href="medscimonit-22-1064-g002"/></fig><fig id="f3-medscimonit-22-1064" position="float"><label>Figure 3</label><caption><p>Light microscopic images of dorsal skin flap: (<bold>A</bold>) Intact control group, (<bold>B</bold>) Sham operated group, (<bold>C</bold>) Placebo group, (<bold>D</bold>) Sericin group. H&#x00026;E staining, original magnification &#x000d7;20, scale bar=250 &#x003bc;m. Yellow arrow shows location of incision line.</p></caption><graphic xlink:href="medscimonit-22-1064-g003"/></fig><fig id="f4-medscimonit-22-1064" position="float"><label>Figure 4</label><caption><p>Mallory Azan staining of the sections images of dorsal skin flap: (<bold>A</bold>) Intact control group, (<bold>B</bold>) Sham operated group, (<bold>C</bold>) Placebo group, (<bold>D</bold>) Sericin group. Original magnification &#x000d7;20, scale bar=250 &#x003bc;m. Small picture magnification &#x000d7;10, scale bar=500 &#x003bc;m. Yellow arrow shows location of incision line.</p></caption><graphic xlink:href="medscimonit-22-1064-g004"/></fig><fig id="f5-medscimonit-22-1064" position="float"><label>Figure 5</label><caption><p>Anti-iNOS staining of the sections images of dorsal skin flap: (<bold>A</bold>) Intact control group, (<bold>B</bold>) Sham operated group, (<bold>C</bold>) Placebo group, (<bold>D</bold>) Sericin group. Original magnification &#x000d7;20, scale bar=250 &#x003bc;m</p></caption><graphic xlink:href="medscimonit-22-1064-g005"/></fig><fig id="f6-medscimonit-22-1064" position="float"><label>Figure 6</label><caption><p>Anti-desmin staining of the sections of dorsal skin flap: (<bold>A</bold>) Intact control group, (<bold>B</bold>) Sham operated group, (<bold>C</bold>) Placebo group, (<bold>D</bold>) Sericin group. Original magnification &#x000d7;20, scale bar=250 &#x003bc;m. Red arrows show <italic>M. arrector pillia</italic>.</p></caption><graphic xlink:href="medscimonit-22-1064-g006"/></fig><table-wrap id="t1-medscimonit-22-1064" position="float"><label>Table 1</label><caption><p>Intergroup comparision of biopsy samples for total and degenerated hair roots and number of vessels.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Group</th><th valign="bottom" align="center" rowspan="1" colspan="1">n</th><th valign="bottom" align="center" rowspan="1" colspan="1">Median</th><th valign="bottom" align="center" rowspan="1" colspan="1">Min</th><th valign="bottom" align="center" rowspan="1" colspan="1">Max</th><th valign="bottom" align="center" rowspan="1" colspan="1">KW&#x003c7;<sup>2</sup><xref ref-type="table-fn" rid="tfn1-medscimonit-22-1064">*</xref></th><th valign="bottom" align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="middle" rowspan="4" align="left" colspan="1">Number of total hair roots</td><td valign="top" align="left" rowspan="1" colspan="1">Intact control<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">43</td><td valign="top" align="right" rowspan="1" colspan="1">38</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="middle" rowspan="4" align="center" colspan="1">21.993</td><td valign="middle" rowspan="4" align="center" colspan="1"><bold>&#x0003c;0.0001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">24</td><td valign="top" align="right" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">29</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">28</td><td valign="top" align="right" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">33</td><td valign="top" align="right" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">36</td></tr><tr><td valign="middle" rowspan="4" align="left" colspan="1">Number of degenerated hair roots</td><td valign="top" align="left" rowspan="1" colspan="1">Intact control</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="right" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="middle" rowspan="4" align="center" colspan="1">13.775</td><td valign="middle" rowspan="4" align="center" colspan="1"><bold>0.001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">24</td><td valign="top" align="right" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">19</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">24</td><td valign="top" align="right" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">31</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">9</td><td valign="top" align="right" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">12</td></tr><tr><td valign="middle" rowspan="4" align="left" colspan="1">Number of vessels</td><td valign="top" align="left" rowspan="1" colspan="1">Intact control<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">40</td><td valign="top" align="right" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">45</td><td valign="middle" rowspan="4" align="center" colspan="1">23.227</td><td valign="middle" rowspan="4" align="center" colspan="1"><bold>&#x0003c;0.0001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">9</td><td valign="top" align="right" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">9</td><td valign="top" align="right" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin<xref ref-type="table-fn" rid="tfn2-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">23</td><td valign="top" align="right" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">30</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-medscimonit-22-1064"><label>*</label><p>Kruskal Wallis Chi Square;</p></fn><fn id="tfn2-medscimonit-22-1064"><label>**</label><p>Post-Hoc p&#x0003c;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-medscimonit-22-1064" position="float"><label>Table 2</label><caption><p>Intergroup comparision of biopsy samples for epidermal thickness and necrotic tissue percentage.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">Group</th><th valign="middle" align="center" rowspan="1" colspan="1">n</th><th valign="middle" align="center" rowspan="1" colspan="1">Mean</th><th valign="middle" align="center" rowspan="1" colspan="1">Standart deviation</th><th valign="middle" align="center" rowspan="1" colspan="1">Min</th><th valign="middle" align="center" rowspan="1" colspan="1">Max</th><th valign="middle" align="center" rowspan="1" colspan="1">KW&#x003c7;<sup>2</sup><xref ref-type="table-fn" rid="tfn1-medscimonit-22-1064">*</xref></th><th valign="middle" align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="middle" rowspan="4" align="left" colspan="1">Epidermal thickness (&#x003bc;m)</td><td valign="top" align="left" rowspan="1" colspan="1">Control<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">39.97</td><td valign="top" align="center" rowspan="1" colspan="1">1.18</td><td valign="top" align="right" rowspan="1" colspan="1">37.94</td><td valign="top" align="right" rowspan="1" colspan="1">41.68</td><td valign="middle" rowspan="4" align="center" colspan="1">22.440</td><td valign="middle" rowspan="4" align="center" colspan="1"><bold>&#x0003c;0.0001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">27.52</td><td valign="top" align="center" rowspan="1" colspan="1">1.44</td><td valign="top" align="right" rowspan="1" colspan="1">25.79</td><td valign="top" align="right" rowspan="1" colspan="1">29.64</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">27.82</td><td valign="top" align="center" rowspan="1" colspan="1">1.95</td><td valign="top" align="right" rowspan="1" colspan="1">24.64</td><td valign="top" align="right" rowspan="1" colspan="1">29.88</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">36.11</td><td valign="top" align="center" rowspan="1" colspan="1">1.96</td><td valign="top" align="right" rowspan="1" colspan="1">33.65</td><td valign="top" align="right" rowspan="1" colspan="1">38.99</td></tr><tr><td valign="middle" rowspan="4" align="left" colspan="1">Necrotic tissue percentage (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Control</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="right" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="right" rowspan="1" colspan="1">&#x02013;</td><td valign="middle" rowspan="4" align="center" colspan="1">13.471</td><td valign="middle" rowspan="4" align="center" colspan="1"><bold>&#x0003c;0.0001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">31.77</td><td valign="top" align="center" rowspan="1" colspan="1">1.95</td><td valign="top" align="right" rowspan="1" colspan="1">31.77</td><td valign="top" align="right" rowspan="1" colspan="1">29.45</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">31.47</td><td valign="top" align="center" rowspan="1" colspan="1">1.55</td><td valign="top" align="right" rowspan="1" colspan="1">31.77</td><td valign="top" align="right" rowspan="1" colspan="1">29.45</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin<xref ref-type="table-fn" rid="tfn4-medscimonit-22-1064">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="right" rowspan="1" colspan="1">7.90</td><td valign="top" align="center" rowspan="1" colspan="1">1.11</td><td valign="top" align="right" rowspan="1" colspan="1">8.34</td><td valign="top" align="right" rowspan="1" colspan="1">6.57</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-medscimonit-22-1064"><label>*</label><p>Kruskal Wallis Chi Square;</p></fn><fn id="tfn4-medscimonit-22-1064"><label>**</label><p>Post-Hoc p &#x0003c;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-medscimonit-22-1064" position="float"><label>Table 3</label><caption><p>The scores for the degree of cellular infiltration.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" rowspan="2" align="center" colspan="1">Groups</th><th colspan="6" valign="middle" align="center" rowspan="1">Cellular infiltration score</th><th valign="middle" rowspan="2" align="center" colspan="1">Total</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">0</th><th valign="middle" align="center" rowspan="1" colspan="1">1</th><th valign="middle" align="center" rowspan="1" colspan="1">2</th><th valign="middle" align="center" rowspan="1" colspan="1">3</th><th valign="middle" align="center" rowspan="1" colspan="1">4</th><th valign="middle" align="center" rowspan="1" colspan="1">5</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Intact control</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham operated</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>2</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>2</bold></td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>2</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>5</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>28</bold></td></tr></tbody></table><table-wrap-foot><fn id="tfn5-medscimonit-22-1064"><p>A score of 0 = &#x02264;3 inflammatory cells, 1 = 3&#x02013;10 inflammatory cells, 2 = 11&#x02013;20 inflammatory cells, 3 = 21&#x02013;30 inflammatory cells, 4 = 31&#x02013;40 inflammatory cells, and 5 = &#x02265;41 inflammatory cells.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-medscimonit-22-1064" position="float"><label>Table 4</label><caption><p>The scores for the degree of edema.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" rowspan="2" align="center" colspan="1">Groups</th><th colspan="6" valign="middle" align="center" rowspan="1">Score for degree of edema</th><th valign="middle" rowspan="2" align="center" colspan="1">Total</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">0</th><th valign="middle" align="center" rowspan="1" colspan="1">1</th><th valign="middle" align="center" rowspan="1" colspan="1">2</th><th valign="middle" align="center" rowspan="1" colspan="1">3</th><th valign="middle" align="center" rowspan="1" colspan="1">4</th><th valign="middle" align="center" rowspan="1" colspan="1">5</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Intact control</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham operated</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>2</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>28</bold></td></tr></tbody></table><table-wrap-foot><fn id="tfn6-medscimonit-22-1064"><p>A score of 0 = normal; 1 = mild increase; 2 = mild to moderate increase; 3 = moderate increase; 4 = moderate to marked increase; 5 = marked increase.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-medscimonit-22-1064" position="float"><label>Table 5</label><caption><p>The scores for the degree of collagen discoloration.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" rowspan="2" align="center" colspan="1">Groups</th><th colspan="6" valign="middle" align="center" rowspan="1">Scores for collagen discoloration</th><th valign="middle" rowspan="2" align="center" colspan="1">Total</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">0</th><th valign="middle" align="center" rowspan="1" colspan="1">1</th><th valign="middle" align="center" rowspan="1" colspan="1">2</th><th valign="middle" align="center" rowspan="1" colspan="1">3</th><th valign="middle" align="center" rowspan="1" colspan="1">4</th><th valign="middle" align="center" rowspan="1" colspan="1">5</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Intact control</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham operated</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>2</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Placebo</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>4</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sericin</td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>1</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" content-type="background-color:#58585A" rowspan="1" colspan="1"><bold>3</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>7</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="right" rowspan="1" colspan="1"><bold>28</bold></td></tr></tbody></table><table-wrap-foot><fn id="tfn7-medscimonit-22-1064"><p>A score of 0 = normal; 1 = mild increase; 2 = mild to moderate increase; 3 = moderate increase; 4 = moderate to marked increase; 5 = marked increase.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6-medscimonit-22-1064" position="float"><label>Table 6</label><caption><p>Malonyldialdehyde (MDA), glutatihion peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) activities in the wound area of the experimental groups.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Sham operated group</th><th valign="bottom" align="center" rowspan="1" colspan="1">Placebo group</th><th valign="bottom" align="center" rowspan="1" colspan="1">Sericin group</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">MDA (nmol/mg)</td><td valign="top" align="center" rowspan="1" colspan="1">0.255&#x000b1;9.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.248&#x000b1;8.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.177&#x000b1;10.2<xref ref-type="table-fn" rid="tfn8-medscimonit-22-1064">*</xref>,<xref ref-type="table-fn" rid="tfn9-medscimonit-22-1064">#</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GPx (mU/ml)</td><td valign="top" align="center" rowspan="1" colspan="1">7.6436&#x000b1;12.3</td><td valign="top" align="center" rowspan="1" colspan="1">7.772&#x000b1;11.5</td><td valign="top" align="center" rowspan="1" colspan="1">11.9708&#x000b1;8.3<xref ref-type="table-fn" rid="tfn8-medscimonit-22-1064">*</xref>,<xref ref-type="table-fn" rid="tfn9-medscimonit-22-1064">#</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SOD (U/ml)</td><td valign="top" align="center" rowspan="1" colspan="1">8.029&#x000b1;11.2</td><td valign="top" align="center" rowspan="1" colspan="1">8.105&#x000b1;10.4</td><td valign="top" align="center" rowspan="1" colspan="1">9.715&#x000b1;8.9<xref ref-type="table-fn" rid="tfn8-medscimonit-22-1064">*</xref>,<xref ref-type="table-fn" rid="tfn9-medscimonit-22-1064">#</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Catalase (U/ml)</td><td valign="top" align="center" rowspan="1" colspan="1">0.3346&#x000b1;10.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.3567&#x000b1;12.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.7832&#x000b1;10.6<xref ref-type="table-fn" rid="tfn8-medscimonit-22-1064">*</xref>,<xref ref-type="table-fn" rid="tfn9-medscimonit-22-1064">#</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn8-medscimonit-22-1064"><label>*</label><p>p&#x0003c;0.001, when compared to sham-operated group;</p></fn><fn id="tfn9-medscimonit-22-1064"><label>#</label><p>p&#x0003c;0.001, when compared to placebo group.</p></fn><fn id="tfn10-medscimonit-22-1064"><p>GPx &#x02013; glutathion peroxidase; MDA &#x02013; malonyldialdehyde; SOD &#x02013; superoxid dismutase.</p></fn></table-wrap-foot></table-wrap></floats-group></article>